Ambeed.cn

首页 / / / / α-Hederin/α-常春藤皂苷

α-Hederin/α-常春藤皂苷 {[allProObj[0].p_purity_real_show]}

货号:A640384 同义名: α常春藤皂甙 / alpha-Hederin; Kalopanaxsaponin A

α-Hederin是一种天然的单糖苷三萜皂苷,具有抗癌潜力,存在于常春藤或黑种草属植物中。

α-Hederin/α-常春藤皂苷 化学结构 CAS号:27013-91-8
α-Hederin/α-常春藤皂苷 化学结构
CAS号:27013-91-8
α-Hederin/α-常春藤皂苷 3D分子结构
CAS号:27013-91-8
α-Hederin/α-常春藤皂苷 化学结构 CAS号:27013-91-8
α-Hederin/α-常春藤皂苷 3D分子结构 CAS号:27013-91-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

α-Hederin/α-常春藤皂苷 纯度/质量文件 产品仅供科研

货号:A640384 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

α-Hederin/α-常春藤皂苷 生物活性

描述 alpha-Hederin (α-hederin), a monodesmosidic triterpenoid saponin, exhibited promising antitumor potential against a variety of human cancer cell lines. α-hederin significantly inhibited the proliferation of gastric cancer cells and arrested the cell cycle in G1 phase in vitro. α-hederin could inhibit the proliferation and induce apoptosis of gastric cancer accompanied by glutathione decrement and reactive oxygen species generation via activating mitochondrial dependent pathway[3]. α-Hederin could inhibit the proliferation and induce apoptosis of ESCC (esophageal squamous cell carcinoma) via dissipation of the MMP (mitochondrial membrane potential) with simultaneous ROS (reactive oxygen species) generation and activation of the mitochondrial pathway[4]. α‑hederin triggered apoptosis through ROS‑activated mitochondrial signaling pathway and autophagic cell death through ROS dependent AMPK(AMP‑activated protein kinase)/mTOR (mechanistic target of rapamycin) signaling pathway activation in colorectal cancer cells[5]. α-hederin suppressed IL-6-induced EMT (Epithelial-mesenchymal transition) associated with disruption of JAK2/STAT3 signaling in colon cancer cells[6].

α-Hederin/α-常春藤皂苷 细胞实验

Cell Line
Concentration Treated Time Description References
HCT116 cells 10 µM 6, 12, 24 h To evaluate the effect of α-Hederin on autophagy in HCT116 cells, results showed that α-Hederin activated the AMPK/mTOR signaling pathway to induce autophagy. Int J Oncol. 2019 May;54(5):1601-1612.
HCT8 cells 0, 10, 60 µM 24 h To evaluate the effect of α-Hederin on apoptosis in HCT8 cells, results showed that α-Hederin induced apoptosis in a dose-dependent manner. Int J Oncol. 2019 May;54(5):1601-1612.
HCT116 cells 0, 10, 60 µM 24 h To evaluate the effect of α-Hederin on apoptosis in HCT116 cells, results showed that α-Hederin induced apoptosis in a dose-dependent manner. Int J Oncol. 2019 May;54(5):1601-1612.
HCT8 cells 0, 2, 4, 8, 16, 32, 64 µM 24, 48, 72 h To evaluate the effect of α-Hederin on the proliferation of colorectal cancer cells, results showed that α-Hederin inhibited the viability of HCT8 cells in a dose- and time-dependent manner. Int J Oncol. 2019 May;54(5):1601-1612.
HCT116 cells 0, 2, 4, 8, 16, 32, 64 µM 24, 48, 72 h To evaluate the effect of α-Hederin on the proliferation of colorectal cancer cells, results showed that α-Hederin inhibited the viability of HCT116 cells in a dose- and time-dependent manner. Int J Oncol. 2019 May;54(5):1601-1612.
NCI-H292 cells 18.04 μM (IC50) 48 h To evaluate the antiproliferative effect of α-Hederin on NCI-H292 cells, results showed that α-Hederin significantly inhibited NCI-H292 cell proliferation. Pharm Biol. 2021 Dec;59(1):11-20.
NCI-H460 cells 17.57 μM (IC50) 48 h To evaluate the antiproliferative effect of α-Hederin on NCI-H460 cells, results showed that α-Hederin significantly inhibited NCI-H460 cell proliferation. Pharm Biol. 2021 Dec;59(1):11-20.
A549 cells 13.75 μM (IC50) 48 h To evaluate the antiproliferative effect of α-Hederin on A549 cells, results showed that α-Hederin significantly inhibited A549 cell proliferation. Pharm Biol. 2021 Dec;59(1):11-20.
HaCaT cells 1–70 μg/mL 24 h To evaluate the effect of α-Hederin on the viability of HaCaT cells, showing an IC50 value of 2.71±0.35 μg/mL Molecules. 2019 Aug 15;24(16):2958.
SKOV-3 cells 1–70 μg/mL 24 h To evaluate the effect of α-Hederin on the viability of SKOV-3 cells, showing an IC50 value of 2.62±0.04 μg/mL Molecules. 2019 Aug 15;24(16):2958.
NCI-H1650 cells 12.5 μM 24 h α-Hed blocked late autophagic flux in NSCLC cells by altering lysosomal pH and inhibiting lysosomal cathepsin D maturation, leading to autophagosome accumulation. Int J Mol Sci. 2018 Oct 18;19(10):3221.
NCI-H1299 cells 12.5 μM 24 h α-Hed blocked late autophagic flux in NSCLC cells by altering lysosomal pH and inhibiting lysosomal cathepsin D maturation, leading to autophagosome accumulation. Int J Mol Sci. 2018 Oct 18;19(10):3221.

α-Hederin/α-常春藤皂苷 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice HCT116 subcutaneous xenograft model Intraperitoneal injection 2 mg/kg Every 3 days for 3 weeks To evaluate the effect of α-Hederin on autophagy in colorectal cancer cells in vivo, results showed that α-Hederin significantly inhibited tumor growth and promoted autophagy. Int J Oncol. 2019 May;54(5):1601-1612.
BALB/c nude mice A549 xenograft tumour model Intraperitoneal injection 5 and 10 mg/kg Every other day for 32 days To evaluate the antitumor effect of α-Hederin on A549 xenograft tumours, results showed that α-Hederin significantly inhibited tumour growth. Pharm Biol. 2021 Dec;59(1):11-20.

α-Hederin/α-常春藤皂苷 参考文献

[1]Cheng L, Xia TS, et al. The anticancer effect and mechanism of α-hederin on breast cancer cells. Int J Oncol. 2014 Aug;45(2):757-63.

[2]Danloy S, Quetin-Leclercq J, et al. Effects of alpha-hederin, a saponin extracted from Hedera helix, on cells cultured in vitro. Planta Med. 1994 Feb;60(1):45-9.

[3]Wang J, Deng H, Zhang J, Wu D, Li J, Ma J, Dong W. α-Hederin induces the apoptosis of gastric cancer cells accompanied by glutathione decrement and reactive oxygen species generation via activating mitochondrial dependent pathway. Phytother Res. 2020 Mar;34(3):601-611

[4]Wang J, Wu D, Zhang J, Liu H, Wu J, Dong W. α-Hederin Induces Apoptosis of Esophageal Squamous Cell Carcinoma via an Oxidative and Mitochondrial-Dependent Pathway. Dig Dis Sci. 2019 Dec;64(12):3528-3538

[5]Sun J, Feng Y, Wang Y, Ji Q, Cai G, Shi L, Wang Y, Huang Y, Zhang J, Li Q. α-hederin induces autophagic cell death in colorectal cancer cells through reactive oxygen species dependent AMPK/mTOR signaling pathway activation. Int J Oncol. 2019 May;54(5):1601-1612

[6]Sun D, Shen W, Zhang F, Fan H, Xu C, Li L, Tan J, Miao Y, Zhang H, Yang Y, Cheng H. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells. Biomed Pharmacother. 2018 May;101:107-114

α-Hederin/α-常春藤皂苷 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.33mL

0.27mL

0.13mL

6.66mL

1.33mL

0.67mL

13.32mL

2.66mL

1.33mL

α-Hederin/α-常春藤皂苷 技术信息

CAS号27013-91-8
分子式C41H66O12
分子量 750.96
SMILES Code O=C([C@]12CCC(C)(C)C[C@@]1([H])C3=CC[C@]4([H])[C@@]5(C)CC[C@H](O[C@H]6[C@H](O[C@H]7[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O7)[C@@H](O)[C@@H](O)CO6)[C@@](C)(CO)[C@]5([H])CC[C@@]4(C)[C@]3(C)CC2)O
MDL No. MFCD00010665
别名 α常春藤皂甙 ;alpha-Hederin; Kalopanaxsaponin A; NSC 106553; Koronaroside A
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 105 mg/mL(139.82 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。